Victor G. Vogel
University of Pittsburgh Cancer Institute/Magee-Womens Hospital
Pennsylvania 15213-3180
USA
Name/email consistency: high
- Recent results from clinical trials using SERMs to reduce the risk of breast cancer. Vogel, V.G. Ann. N. Y. Acad. Sci. (2006)
- Atypia in the assessment of breast cancer risk: implications for management. Vogel, V.G. Diagn. Cytopathol. (2004)
- National surgical adjuvant breast and bowel project update: prevention trials and endocrine therapy of ductal carcinoma in situ. Vogel, V.G., Costantino, J.P., Wickerham, D.L., Cronin, W.M. Clin. Cancer Res. (2003)
- Update on breast cancer prevention. Rastogi, P., Vogel, V.G. Oncology (Williston Park, N.Y.) (2003)
- Management of the high-risk patient. Vogel, V.G. Surg. Clin. North Am. (2003)
- The study of tamoxifen and raloxifene: preliminary enrollment data from a randomized breast cancer risk reduction trial. Vogel, V.G., Costantino, J.P., Wickerham, D.L., Cronin, W.M., Wolmark, N. Clin. Breast Cancer (2002)
- Reducing the risk of breast cancer with tamoxifen in women at increased risk. Vogel, V.G. J. Clin. Oncol. (2001)
- Follow-up of the breast cancer prevention trial and the future of breast cancer prevention efforts. Vogel, V.G. Clin. Cancer Res. (2001)